Literature DB >> 22328241

Nasal versus oronasal raised volume forced expirations in infants--a real physiologic challenge.

Mohy G Morris1.   

Abstract

Raised volume rapid thoracoabdominal compression (RTC) generates forced expiration (FE) in infants typically from an airway opening pressure of 30 cm H(2)O (V(30)). We hypothesized that the higher nasal than pulmonary airway resistance limits forced expiratory flows (FEF(%)) during (nasal) FE(n), which an opened mouth, (oronasal) FE(o), would resolve. Measurements were performed during a brief post-hyperventilation apnea on 12 healthy infants aged 6.9-104 weeks. In two infants, forced expiratory (FEFV) flow volume (FV) curves were generated using a facemask that covered the nose and a closed mouth, then again with a larger mask with the mouth opened. In other infants (n = 10), the mouth closed spontaneously during FE. Oronasal passive expiration from V(30) generated either the inspiratory capacity (IC) or by activating RTC before end-expiration, the slow vital capacity ((j) SVC). Peak flow (PF), FEF(25), FEF(50), FEF(25-75), FEV(0.4), and FEV(0.5) were lower via FE(n) than FE(o) (P < 0.05), but the ratio of expired volume at PF and forced vital capacity (FVC) as percent was higher (P < 0.05). FEF(75), FEF(85), FEF(90), FVC as well as the applied jacket pressures were not different (P > 0.05). FEFV curves generated via FE(o) exhibited higher PF than FV curves of IC (P < 0.05); PF of those produced via FE(n) were not different from FV curves of IC (P > 0.05) but lower than those of (j) SVC (P < 0.05). In conclusion, the higher nasal than pulmonary airways resistance unequivocally affects the FEFV curves by consistently reducing PF and decreases mid-expiratory flows. A monitored slightly opened mouth and a gentle anterior jaw thrust are physiologically integral for raised volume RTC in order to maximize the oral and minimize nasal airways contribution to FE so that flow limitation would be in the pulmonary not nasal airways.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22328241      PMCID: PMC3395775          DOI: 10.1002/ppul.22509

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  70 in total

1.  Relationship between maximum expiratory flow and degree of lung inflation.

Authors:  R E HYATT; D P SCHILDER; D L FRY
Journal:  J Appl Physiol       Date:  1958-11       Impact factor: 3.531

2.  The response to beta-agonists in wheezy infants: three methods compared.

Authors:  Caroline S Beardsmore; Catherine Page; Michael Silverman
Journal:  Respir Med       Date:  2004-11       Impact factor: 3.415

Review 3.  Opening the upper airway--airway maneuvers in pediatric anesthesia.

Authors:  Britta S von Ungern-Sternberg; Thomas O Erb; Adrian Reber; Franz J Frei
Journal:  Paediatr Anaesth       Date:  2005-03       Impact factor: 2.556

4.  A neuromuscular mechanism maintaining extrathoracic airway patency.

Authors:  R T Brouillette; B T Thach
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-04

Review 5.  Maintenance of upper airway patency.

Authors:  O P Mathew
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

Review 6.  Expiratory flow limitation.

Authors:  R E Hyatt
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-07

7.  Expiratory flow limitation: a physiologist's point of view.

Authors:  J Mead
Journal:  Fed Proc       Date:  1980-08

8.  A novel non-invasive technique for measuring the residual lung volume by nitrogen washout with rapid thoracoabdominal compression in infants.

Authors:  M G Morris
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

9.  The effect of chloral hydrate on genioglossus and diaphragmatic activity.

Authors:  M Hershenson; R T Brouillette; E Olsen; C E Hunt
Journal:  Pediatr Res       Date:  1984-06       Impact factor: 3.756

10.  Factors influencing regional patency and configuration of the human infant upper airway.

Authors:  W R Reed; J L Roberts; B T Thach
Journal:  J Appl Physiol (1985)       Date:  1985-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.